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Clinics and pathology 
Disease 
Acute non lymphoblastic leukemia (ANLL) and 
myelodysplastic syndromes (MDS); de novo ANLL 
and treatment related leukemias (t-ANLL). 
Phenotype/cell stem origin 
One M2, one treatment related RAEBt/M4, one t-
ANLL. 
Etiology 
Two cases are secondary to treatment with 
topoisomerase II inhibitors for Hodgkin disease and 
neuroblastoma. 
Epidemiology 





Sole anomaly in one case; one case was also -7, +8, one 
case showed also a t(11;12)(p15;q13) with NUP98 
rearrangement. 
Genes involved and proteins 
Note 
The gene involved in 17q11 is unknown; the breakpoint 






Transcription is from telomere to centromere. 
Protein 
Contains a Runt domain and, in the C-term, a 
transactivation domain; forms heterodimers; widely 
expressed; nuclear localisation; transcription factor 
(activator) for various hematopoietic-specific genes. 




5 prime AML1-3 prime unknown; breakpoint in intron 
5 or 6 of AML1. 
Fusion protein 
Description 
The N-term is provided by AML1, as in the t(3;21) and 
in the t(8;21) associated with ANLLs, whereas, in the 
ALL with t(12;21), the fusion protein comprises the C-
term part of AML1. 
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